Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barré syndrome

Soluble receptor for advanced glycation end products (sRAGE) is an anti-inflammatory factor that mitigates the proinflammatory effects of high mobility group box 1 (HMGB1). The aim of this study was to investigate whether Guillain-Barré syndrome (GBS)-related inflammation are mediated by sRAGE and H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Da-Qi, Wang, Rong, Li, Ting, Zhou, Jian-Ping, Chang, Guo-Qiang, Zhao, Ning, Yang, Li-Na, Zhai, Hui, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763208/
https://www.ncbi.nlm.nih.gov/pubmed/26902096
http://dx.doi.org/10.1038/srep21890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763208/
https://www.ncbi.nlm.nih.gov/pubmed/26902096
http://dx.doi.org/10.1038/srep21890

Ejemplares similares